On CNBC's "Mad Money Lightning Round," Jim Cramer said he wouldn't buy Teva Pharmaceutical Industries Ltd TEVA. He explained that it's a generic drugmaker and those stocks are pretty awful in comparison to Merck & Co., Inc. MRK, Pfizer Inc. PFE and Bristol-Myers Squibb Co BMY.
Instead of Oxford Industries Inc OXM, Cramer would rather buy PVH Corp PVH.
Cramer likes Amgen, Inc. AMGN and its new oncological franchise.
He prefers Advanced Micro Devices, Inc. AMD over Intel Corporation INTC. He believes AMD will take some market share from Intel with its new chips.
Cramer said the CEO of General Electric Company GE is doing a fantastic job against tremendous circumstances, but he doesn't see the investment in the stock as a diversification strategy.
Cramer likes SpartanNash Co SPTN a lot. He thinks that something must be going on and he sees the stock as a good one.
He would sell a half of a position in Ingevity Corp NGVT and let the rest run.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
